Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Moss

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Clinical and Experimental Immunology|June 9, 2000
Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytesR B Moss, Y P Hsu, L Olds
Chest|February 23, 1999
Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazoleI B Nepomuceno, S Esrig, R B Moss
The Journal of Pediatrics|August 1, 1981
125I-Clq-binding and specific antibodies as indicators of pulmonary disease activity in cystic fibrosisR B Moss, Y P Hsu, N J Lewiston
Clinical Immunology (Orlando, Fla.)|April 26, 2000
Insights into HIV-specific immune function: implications for therapy and prevention in the new millenniumR B Moss, F C Jensen, D J Carlo
The American Journal of Medicine|January 1, 1994
Osteopenia in adults with cystic fibrosisL K Bachrach, C W Loutit, R B Moss
Vaccine|December 11, 1999
In vitro immune function after vaccination with an inactivated, gp120-depleted HIV-1 antigen with immunostimulatory oligodeoxynucleotidesR B Moss, J Diveley, F Jensen, et al.
Pediatrics|February 7, 2001
Comprehensive mutation screening in a cystic fibrosis centerJ J Wine, E Kuo, G Hurlock, et al.
Pediatrics|November 1, 1985
Cystic fibrosis and neuroblastomaR B Moss, J Blessing-Moore, S W Bender, et al.
Journal of Clinical Orthodontics : JCO|June 1, 1990
Orthodontic management of ankylosed teethM K Phelan, R B Moss, R S Powell, et al.
Current Drug Targets. Infectious Disorders|November 29, 2002
The strategy of immunologic control of HIV-1 with structured treatment interruptions (STIs)R B Moss, F C Jensen, D J Carlo, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Immunology|June 9, 2000
Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytesR B Moss, Y P Hsu, L Olds
Chest|February 23, 1999
Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazoleI B Nepomuceno, S Esrig, R B Moss
The Journal of Pediatrics|August 1, 1981
125I-Clq-binding and specific antibodies as indicators of pulmonary disease activity in cystic fibrosisR B Moss, Y P Hsu, N J Lewiston
Clinical Immunology (Orlando, Fla.)|April 26, 2000
Insights into HIV-specific immune function: implications for therapy and prevention in the new millenniumR B Moss, F C Jensen, D J Carlo
The American Journal of Medicine|January 1, 1994
Osteopenia in adults with cystic fibrosisL K Bachrach, C W Loutit, R B Moss
Vaccine|December 11, 1999
In vitro immune function after vaccination with an inactivated, gp120-depleted HIV-1 antigen with immunostimulatory oligodeoxynucleotidesR B Moss, J Diveley, F Jensen, et al.
Pediatrics|February 7, 2001
Comprehensive mutation screening in a cystic fibrosis centerJ J Wine, E Kuo, G Hurlock, et al.
Pediatrics|November 1, 1985
Cystic fibrosis and neuroblastomaR B Moss, J Blessing-Moore, S W Bender, et al.
Journal of Clinical Orthodontics : JCO|June 1, 1990
Orthodontic management of ankylosed teethM K Phelan, R B Moss, R S Powell, et al.
Current Drug Targets. Infectious Disorders|November 29, 2002
The strategy of immunologic control of HIV-1 with structured treatment interruptions (STIs)R B Moss, F C Jensen, D J Carlo, et al.
Pageof 12